CLINUVEL
Posted by CLINUVEL
July 31, 2020

Appendix 4C – quarterly

CLINUVEL PHARMACEUTICALS LTD today announced its Appendix 4C – Quarterly Cashflow Report...

Read More
CLINUVEL
Posted by CLINUVEL
July 23, 2020

Kommuniqué IV

Liebe Aktionäre, Freunde Es stellt sich eine neue Welt dar, die darauf...

Read More
CLINUVEL
Posted by CLINUVEL
July 22, 2020

CLINUVEL Newsletter

Dear shareholders, friends, As a new world presents itself indicating that the...

Read More
CLINUVEL
Posted by CLINUVEL
July 13, 2020

Media Release - Second Afamelanotide Formulation

PRÉNUMBRA®- CLINUVEL’S SECOND AFAMELANOTIDE FORMULATION Drug to be evaluated in patients with...

Read More
CLINUVEL
Posted by CLINUVEL
July 13, 2020

PRÉNUMBRA® – New Liquid Afamelanotide Presentation

EXECUTIVE SUMMARY • PRÉNUMBRA® non-solid dosage form of afamelanotide • Active life-cycle...

Read More
We use cookies to give you the best experience.